Clinical Trial Update: A Clinical Trial to Evaluate Efficacy and Safety of TransCon CNP Compared With Placebo in Infants (0 to <2 Years of Age) With Achondroplasia [Phase 2]

View source ↗

Summary

A Phase 2 trial in infants (0 to <2 years) with achondroplasia evaluating the efficacy and safety of TransCon CNP vs placebo; recruiting status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Achondroplasia

Drugs mentioned

• TransCon CNP (C-type natriuretic peptide prodrug)

Snippet

Sponsor: Ascendis Pharma A/S | Conditions: Achondroplasia | Phase 2 | Status: RECRUITING